Skip to main content
TipRanks
Go Ultimate75% OFF

Seoul Pharma Co., Ltd. (018680) Q2 2022 Earnings Report

KR:018680 Q2 2022 EPS Results

Actual EPS
-KRW 4.36
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-KRW 156.12

KR:018680 Q2 2022 Revenue Results

Actual Revenue
KRW 12.26B
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2022
Date
08/12/2022
Time
TBA
Conference Call
Friday, August 12, 2022
KR:018680 Upcoming Earnings

Seoul Pharma Co., Ltd.'s next earnings date is estimated for March 24, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

KR:018680 Earnings History

KR:018680 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 24, 20272026 (Q4)―--32.22――
Nov 13, 20262026 (Q3)―-225.07―
Aug 14, 20262026 (Q2)―-27.25-114.1376.13% (+86.89)
May 15, 20262026 (Q1)―-16.46-14.08-16.91% (-2.38)
Mar 19, 20262025 (Q4)―-32.2256.7-156.82% (-88.91)
Nov 14, 20252025 (Q3)―225.0714.841417.17% (+210.24)
Aug 14, 20252025 (Q2)―-114.1323.32-589.48% (-137.45)
May 15, 20252025 (Q1)―-14.0850.84-127.70% (-64.92)
Mar 20, 20252024 (Q4)―56.7032.4274.88% (+24.28)
Nov 14, 20242024 (Q3)―14.84-36.92140.18% (+51.75)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed